FDA Inspection 1190291 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on October 27, 2022 in Raynham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 27, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Raynham, MA (United States)